The option premiums don't reflect your pessimism though... I wonder why?
Because there is a retail sucker born every minute in the market for dev-stage biotech options?
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr